Body size and thyroid cancer in two million Norwegian men and women

por Engeland, A, Tretli, S, Akslen, L A, Bjørge, T
Publicado 2006

The views and practice of oncologists towards nutritional support in patients receiving chemotherapy

por Spiro, A, Baldwin, C, Patterson, A, Thomas, J, Andreyev, H J N
Publicado 2006

Survival of death certificate initiated registrations: selection bias, incomplete trace-back or higher mortality?

por Silcocks, P
Publicado 2006

Increased risk of venous thromboembolism in patients with acute leukaemia

por Mohren, M, Markmann, I, Jentsch-Ullrich, K, Koenigsmann, M, Lutze, G, Franke, A
Publicado 2006

Association of body mass index and height with risk of prostate cancer among middle-aged Japanese men

por Kurahashi, N, Iwasaki, M, Sasazuki, S, Otani, T, Inoue, M, Tsugane, S
Publicado 2006

Tumours and tremors: how PTEN regulation underlies both

por Kim, R H, Mak, T W
Publicado 2006

Towards third generation matrix metalloproteinase inhibitors for cancer therapy

por Overall, C M, Kleifeld, O
Publicado 2006

Is nonangiogenesis a novel pathway for cancer progression? A study using 3-dimensional tumour reconstructions

por Adighibe, O, Micklem, K, Campo, L, Ferguson, M, Harris, A, Pozos, R, Gatter, K, Pezzella, F
Publicado 2006

Controlled clinical trials in cancer pain. How controlled should they be? A qualitative systematic review

por Bell, R F, Wisløff, T, Eccleston, C, Kalso, E
Publicado 2006

Crosstalk between the EGFR and other signalling pathways at the level of the global transcriptional corepressor Groucho/TLE

por Hasson, P, Paroush, Z
Publicado 2006

Profiling influences of senescent and aged fibroblasts on prostate carcinogenesis

por Dean, J P, Nelson, P S
Publicado 2008

Association of childhood acute lymphoblastic leukaemia with cancers in family members

por Couto, E, Chen, B, Hemminki, K
Publicado 2005

Potential for improvement of docetaxel-based chemotherapy: a pharmacological review

por Engels, F K, Sparreboom, A, Mathot, R A A, Verweij, J
Publicado 2005

Age adjustment of cancer survival rates: methods, point estimates and standard errors

por Brenner, H, Hakulinen, T
Publicado 2005

Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer

por Iaffaioli, R V, Formato, R, Tortoriello, A, Del Prete, S, Caraglia, M, Pappagallo, G, Pisano, A, Fanelli, F, Ianniello, G, Cigolari, S, Pizza, C, Marano, O, Pezzella, G, Pedicini, T, Febbraro, A, Incoronato, P, Manzione, L, Ferrari, E, Marzano, N, Quattrin, S, Pisconti, S, Nasti, G, Giotta, G, Colucci, G
Publicado 2005

Recent clinical studies of the immunomodulatory drug (IMiD®) lenalidomide

por Bartlett, J B, Tozer, A, Stirling, D, Zeldis, J B
Publicado 2005

Cancer chemoprevention: lessons learned and future directions

por Brenner, D E, Gescher, A J
Publicado 2005

Toenail selenium concentrations and bladder cancer risk in women and men

por Michaud, D S, De Vivo, I, Morris, J S, Giovannucci, E
Publicado 2005

The metastasis associated protein S100A4: role in tumour progression and metastasis

por Helfman, D M, Kim, E J, Lukanidin, E, Grigorian, M
Publicado 2005

Evolving treatment strategies for myeloma

por Morgan, G J, Davies, F E
Publicado 2005